+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Immune Disorders Drugs Market Research Reports

Interferon - Biosimilar Insight, 2022 - Product Thumbnail Image

Interferon - Biosimilar Insight, 2022

  • Report
  • January 2022
  • 70 Pages
  • Global
From
Infliximab-Biosimilars Insight, 2022 - Product Thumbnail Image

Infliximab-Biosimilars Insight, 2022

  • Report
  • January 2022
  • 90 Pages
  • Global
From
Adalimumab-Biosimilars Insight, 2022 - Product Thumbnail Image

Adalimumab-Biosimilars Insight, 2022

  • Report
  • January 2022
  • 90 Pages
  • Global
From
Pemphigus Vulgaris (PV)-Epidemiology Forecast - 2032 - Product Thumbnail Image

Pemphigus Vulgaris (PV)-Epidemiology Forecast - 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Microscopic Polyangiitis (MPA) - Market Insight, Epidemiology and Market Forecast -2032 - Product Thumbnail Image

Microscopic Polyangiitis (MPA) - Market Insight, Epidemiology and Market Forecast -2032

  • Report
  • January 2022
  • 200 Pages
  • Global
From
Microscopic Polyangiitis (MPA)- Epidemiology Forecast to 2032 - Product Thumbnail Image

Microscopic Polyangiitis (MPA)- Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Chronic Rhinosinusitis without Nasal Polyps (CRSsNP) - Market Insight, Epidemiology and Market Forecast -2032 - Product Thumbnail Image

Chronic Rhinosinusitis without Nasal Polyps (CRSsNP) - Market Insight, Epidemiology and Market Forecast -2032

  • Report
  • January 2022
  • 200 Pages
  • Global
From
Chronic Rhinosinusitis without Nasal Polyps - Epidemiology Forecast to 2032 - Product Thumbnail Image

Chronic Rhinosinusitis without Nasal Polyps - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Rheumatoid Arthritis - Market Insight, Epidemiology and Market Forecast -2032 - Product Thumbnail Image

Rheumatoid Arthritis - Market Insight, Epidemiology and Market Forecast -2032

  • Report
  • January 2022
  • 200 Pages
  • Global
From
Tadekinig Alfa - Emerging Insight and Market Forecast - 2030 - Product Thumbnail Image

Tadekinig Alfa - Emerging Insight and Market Forecast - 2030

  • Report
  • April 2021
  • 35 Pages
  • Global
From
Ilaris - Drug Insight and Market Forecast - 2030 - Product Thumbnail Image

Ilaris - Drug Insight and Market Forecast - 2030

  • Report
  • December 2020
  • 60 Pages
  • Global
From
ANAKINRA - Emerging Insight and Market Forecast - 2030 - Product Thumbnail Image

ANAKINRA - Emerging Insight and Market Forecast - 2030

  • Report
  • December 2020
  • 60 Pages
  • Global
From
PD-1 and PD-L1 Inhibitors - Competitive Landscape, Market and Pipeline Analysis, 2020 - Product Thumbnail Image

PD-1 and PD-L1 Inhibitors - Competitive Landscape, Market and Pipeline Analysis, 2020

  • Drug Pipelines
  • March 2020
  • 100 Pages
  • Global
From
Crohn's Disease Therapeutics Market Size and Forecast 2021 - 2031, Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Drug Class, Distribution Channel, and Geography - Product Thumbnail Image

Crohn's Disease Therapeutics Market Size and Forecast 2021 - 2031, Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Drug Class, Distribution Channel, and Geography

  • Report
  • March 2024
  • 150 Pages
  • Global
From
India Lymphedema Treatment Market Forecast 2020-2030, and Country Share, Trend, and Growth Opportunity Analysis Coverage: Condition Type, Treatment Type, and End User - Product Thumbnail Image

India Lymphedema Treatment Market Forecast 2020-2030, and Country Share, Trend, and Growth Opportunity Analysis Coverage: Condition Type, Treatment Type, and End User

  • Report
  • October 2023
  • 85 Pages
  • India
From
North America Intravenous Immunoglobulin Market Size and Forecasts 2020-2030, Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Type, Application, Distribution Channel, End User, and Country - Product Thumbnail Image

North America Intravenous Immunoglobulin Market Size and Forecasts 2020-2030, Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Type, Application, Distribution Channel, End User, and Country

  • Report
  • October 2023
  • 107 Pages
  • North America
From
Middle East and Africa Intravenous Immunoglobulin Market Forecast to 2028 - COVID-19 Impact and Regional Analysis - by Type, Form, and Application - Product Thumbnail Image

Middle East and Africa Intravenous Immunoglobulin Market Forecast to 2028 - COVID-19 Impact and Regional Analysis - by Type, Form, and Application

  • Report
  • December 2022
  • 171 Pages
  • Middle East, Africa
From
South America Intravenous Immunoglobulin Market Forecast to 2028 - COVID-19 Impact and Regional Analysis - by Type, Form, and Application - Product Thumbnail Image

South America Intravenous Immunoglobulin Market Forecast to 2028 - COVID-19 Impact and Regional Analysis - by Type, Form, and Application

  • Report
  • December 2022
  • 161 Pages
From
Asia-Pacific Intravenous Immunoglobulin Market Forecast to 2028 - COVID-19 Impact and Regional Analysis - by Type, Form, and Application - Product Thumbnail Image

Asia-Pacific Intravenous Immunoglobulin Market Forecast to 2028 - COVID-19 Impact and Regional Analysis - by Type, Form, and Application

  • Report
  • December 2022
  • 181 Pages
  • Asia Pacific
From
Europe Intravenous Immunoglobulin Market Forecast to 2028 - COVID-19 Impact and Regional Analysis - by Type, Form, and Application - Product Thumbnail Image

Europe Intravenous Immunoglobulin Market Forecast to 2028 - COVID-19 Impact and Regional Analysis - by Type, Form, and Application

  • Report
  • December 2022
  • 186 Pages
  • Europe
From
Loading Indicator

The Immune Disorders Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs to treat immune system disorders. These drugs are used to treat a variety of conditions, including allergies, asthma, autoimmune diseases, and cancer. Immune Disorders Drugs are designed to target specific parts of the immune system, such as cytokines, antibodies, and T-cells, to reduce inflammation and improve the body's ability to fight off infection. The Immune Disorders Drugs market is highly competitive, with many large pharmaceutical companies competing for market share. Some of the major players in the market include AbbVie, AstraZeneca, Bristol-Myers Squibb, GlaxoSmithKline, Merck, Novartis, Pfizer, and Roche. These companies are constantly researching and developing new drugs to treat immune system disorders, as well as improving existing treatments. Show Less Read more